britt E

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has received conditional approval in China as a monotherapy for the treatment of adult patients with locally advanced or metastatic HER2-positive gastric or […]

Debbie’s Dream Foundation: Curing Stomach Cancer shared on LinkedIn: “New Interview Alert! Our CEO, Andrea Eidelman, sat down with OncoDaily’s Editor-in-Chief, Gevorg Tamamyan, for a powerful conversation about the mission of Debbie’s Dream Foundation: Curing […]

Gastric cancer (GC) is characterized with differentiation disorders, the precise mechanisms of which remain unknown. Our previous study showed that PHF10 exhibits oncogenic properties in GC, with its histological presentation […]

Cancer With the Help of an AACR Grant Valerie O’Brien, PhD, is using her microbiology expertise to model and study gastric cancer development with early support from a Debbie’s Dream […]

Combination therapy with evorpacept (ALX148), trastuzumab (Herceptin), ramucirumab (Cyramza), and paclitaxel (TRP) meaningfully improved overall response rate (ORR) and duration of response (DOR) compared with TRP alone among those with […]

In 2011, a Chinese research team began visiting nearly 1000 villages in Shandong province to launch an unprecedented cancer prevention experiment. A simple breath test given to more than 180,000 […]

“The National Institute for Health and Care Excellence (NICE) has recommended the use of the immunotherapy drug pembrolizumab (also known as Keytruda) as an option for people with advanced gastric […]

In a recent study published in The Lancet Public Health, researchers assessed cancer incidence and mortality trends in the United States (US). Previously, the authors reported an increased incidence of […]